放疗对晚期胃癌相关胃出血的疗效
本研究回顾性分析了57例因晚期胃癌胃出血接受姑息性放疗的患者,中位生物有效剂量(α/β=10)为37.5 Gy,最常见方案为25 Gy分5次。放疗后血红蛋白水平较放疗前显著升高(均p<0.001),且不同总剂量、分次剂量和分次数的再出血率无显著差异。止血控制与肿瘤部分缓解及总生存改善相关。
要点
- 放疗后血红蛋白较基线显著升高,即刻、1个月和2个月均值分别为9.7、10.3和9.7 g/dL。
- 再出血率在不同总剂量、分次剂量和分次数间无显著差异。
- 止血控制者肿瘤部分缓解率更高(25.0% vs 10.8%,p=0.023),3个月内止血控制者总生存更优(中位15.4 vs 10.0周,p=0.048)。
核心结论
- 放疗是控制胃癌胃出血的有效手段,短程五分割方案即可实现止血。
研究设计与样本
- 回顾性分析2009年1月至2019年2月间57例接受姑息性放疗的晚期胃癌胃出血患者。
主要发现
- 放疗前、放疗后即刻、1个月和2个月的平均血红蛋白分别为6.6、9.7、10.3和9.7 g/dL,均显著高于放疗前(均p<0.001)。
- 总剂量、分次剂量和分次数对再出血率无显著影响。
- 放疗后2个月内CT评估的胃肿瘤部分缓解在止血控制患者中更常见(25.0% vs 10.8%,p=0.023)。
- 放疗后3个月内实现止血控制者总生存显著改善(中位15.4 vs 10.0周,p=0.048)。
关键数值与推荐
- 中位生物有效剂量(α/β=10)为37.5 Gy(范围23.6-58.5 Gy)。
- 最常见放疗方案为25 Gy分5次。
- 再出血定义为放疗后血红蛋白降至<7.0 g/dL或接受输血。
临床怎么用
- 对晚期胃癌合并胃出血患者,可考虑短程五分割放疗(如25 Gy/5次)进行姑息止血。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gastric bleeding negatively impacts the quality of life of patients with unresectable advanced gastric cancer and is frequently lethal. We investigated the efficacy of RT for palliation of gastric bleeding from gastric cancer and identified an optimal radiotherapy (RT) strategy. METHODS: The study analyzed 57 patients submitted to palliative RT for gastric bleeding associated with gastric cancer between January 2009 and February 2019. Changes in hemoglobin (Hb) levels were analyzed based on measurements taken before and immediately, 1 month, and 2 months after RT. Re-bleeding after RT was identified as either Hb level dropping to < 7.0 g/dL or the administration of a blood transfusion after RT. RESULTS: The median biologically effective dose (α/β = 10) was 37.5 Gy (range 23.6-58.5). The most common regimen was 25 Gy in five fractions. The mean Hb levels before, immediately after, 1 month, and 2 months after RT (6.6, 9.7, 10.3, and 9.7 g/dL, respectively) were significantly higher than that before RT (all p < 0.001). No significant differences in re-bleeding rates were observed according to total dose, fractional dose, and fraction number. Gastric tumor response evaluated by computed tomography within 2 months after RT showed partial responses were more frequent in patients achieving bleeding control (25.0% vs. 10.8%, p = 0.023) and overall survival was significantly improved for bleeding control within 3 months after RT (median, 15.4 vs. 10.0 weeks, p = 0.048). CONCLUSIONS: RT was an effective modality for gastric bleeding control in gastric cancer, which can be achieved with a short course scheme with five fractions.
引用
- Lee J, Byun HK, Koom WS, et al. Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer. Radiat Oncol. 2021. PMID: 34425855. doi:10.1186/s13014-021-01884-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。